Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Medical Countermeasures WHO Launches Clinical Trial of Two Experimental Ebola Treatments in DRCGlobal Biodefense StaffJune 25, 2026
Medical Countermeasures Experimental Two-in-One Vaccine Shows Early Promise Against Lassa Fever and RabiesGlobal Biodefense StaffJune 19, 2026
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox Medical Countermeasures October 4, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine Medical Countermeasures August 12, 2018 …
Landmark Ebola Study Provides Deep Scan of Therapeutic Antibody Combinations Medical Countermeasures August 9, 2018 …
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994 Antimicrobial Resistance July 16, 2018 …
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine Medical Countermeasures July 12, 2018 …
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments Medical Countermeasures May 18, 2018 …
Army Developing Implantable Sustained-Release Malaria Countermeasure Contracts + Grants May 13, 2018 …
Project BioShield: HHS Purchases Anthrax Countermeasure from Elusys Therapeutics Medical Countermeasures April 23, 2018 …
